Zoetis

Zoetis (ZTS) is a publicly traded company in the Health Care sector, specifically within the Pharmaceuticals industry. Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

The company reports trailing twelve-month revenue of $2.26B and net income of $601.00M.

Key metrics include a return on equity of 18.6%, a debt-to-equity ratio of 3.69.

Investors tracking ZTS can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.